Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Neonatal Med. 2016 May;23(2):121-126. Korean. Case Report. https://doi.org/10.5385/nm.2016.23.2.121
Kim YJ , Kim YD , Choi JH .
Department of Pediatrics, Jeju National University School of Medicine, Jeju, Korea. cardios@hanmail.net
Abstract

The incidence of symptomatic thrombosis of umbilical arterial catheterization is 1-3%. Therapeutic options may include: using heparin or low molecular weight heparin, using a thrombolytic agent, or surgical thrombectomy. However, there are insufficient data to recommend any one treatment over the others. Recently, enoxaparin, a low molecular weight heparin, has emerged as a drug of choice for the treatment of neonatal thrombosis due to pharmacologic stability over unfractionated heparin or thrombolytic agents. We report a case of successful treatment of aortic thrombosis after umbilical arterial catheterization with enoxaparin in preterm infants.

Copyright © 2019. Korean Association of Medical Journal Editors.